Oxcarbazepine Tablets Recalled Due to Labeling Error
American Health Packaging is recalling Oxcarbazepine Tablets due to a label mix-up with Ibuprofen tablets.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as a Class I recall, which per the rubric mandates a score of at least 4 due to the potential for serious adverse health consequences from taking the wrong medication.
Plain-English summary
American Health Packaging is recalling Oxcarbazepine Tablets, 300 mg, NDC 62584-143-01, Lot #142544. The recall was initiated because some cartons were found to be mis-labeled with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544, while the cartons actually contained AHP Ibuprofen Tablets, USP, 600mg, lot #142588.
The affected product was distributed nationwide and in Puerto Rico. The recall involves 59,200 tablets. The agency has classified this recall as Class I.
Consumers should check their medication for the specific lot number and expiration date listed in the recall notice. If the product matches the description, they should stop using it and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- Oxcarbazepine Tablets, 300 mg, 100 tablets per carton (10 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, OH 43217, NDC 62584-143-01
- Manufacturer
- American Health Packaging
- Category
- Drug — Prescription Medication
- Affected units
- 59,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #142544
- Exp 02/2016
Distribution
Part of a larger recall action
This product is one of 2 recalled by American Health Packaging under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · American Health Packaging
See all →- LowBuprenorphine Sublingual Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-09-09
- ModerateNitrofurantoin Capsules 100 mg recalled for failed dissolution specifications
FDA (Drugs) · 2022-05-25
- ModerateCyanocobalamin Injection Recalled Due to Subpotency and Assay Non-Compliance
FDA (Drugs) · 2022-05-04
- SevereOxycodone Hydrochloride Oral Solution Recall Due to Impurity Failure
FDA (Drugs) · 2022-03-16
- ModerateMetoprolol Succinate ER Tablets Recall for Failed Dissolution
FDA (Drugs) · 2022-02-02
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls OXcarbazepine Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls OXcarbazepine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- LowDesmopressin Acetate Tablets Recalled for Incorrect Imprint
FDA (Drugs) · 2015-07-22
- LowNabumetone Tablets Recalled for Missing Medication Guide Labeling
FDA (Drugs) · 2020-07-01
- LowBuprenorphine Sublingual Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-09-09
- ModerateAidapak Recalls Ascorbic Acid Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29